On June 30, 2011
Drugmaker Lilly Is Sinking — but Its CEO Rejects an M&A Life Raft
Even though it’s facing revenue declines of $7 billion, Lilly says it will not acquire, merge or diversify its product line. And thus it won’t start growing sales again until "after 2014."
No tags for this post.
0 Comments